Metabolomics Approach in Allergic and Rheumatic Diseases
暂无分享,去创建一个
Cesare Manetti | M. Valerio | Luca Casadei | C. Manetti | R. Scrivo | R. Priori | G. Valesini | Guido Valesini | Mariacristina Valerio | Rossana Scrivo | Luca Casadei | Roberta Priori | L. Casadei
[1] P. J. Barnes,et al. Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.
[2] Douglas B. Kell,et al. Proposed minimum reporting standards for data analysis in metabolomics , 2007, Metabolomics.
[3] T. Lundstedt,et al. Diagnostic properties of metabolic perturbations in rheumatoid arthritis , 2011, Arthritis Research & Therapy.
[4] M. Valerio,et al. Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. , 2013, Autoimmunity reviews.
[5] A. Boner,et al. An exploratory 1H‐nuclear magnetic resonance metabolomics study reveals altered urine spectral profiles in infants with atopic dermatitis , 2012, The British journal of dermatology.
[6] P. Sarzi-Puttini,et al. Predicting response to anti-TNF treatment in rheumatoid arthritis patients. , 2009, Autoimmunity reviews.
[7] A. Barton,et al. Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies , 2011, Annals of the rheumatic diseases.
[8] J. Lindon,et al. Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.
[9] J. Griffin. Metabolic profiles to define the genome: can we hear the phenotypes? , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[10] B. Shushan. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. , 2010, Mass spectrometry reviews.
[11] S. Rantapää-Dahlqvist,et al. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. , 1991, Annals of the rheumatic diseases.
[12] H. Peh,et al. Metabolomics reveals altered metabolic pathways in experimental asthma. , 2013, American journal of respiratory cell and molecular biology.
[13] Károly Héberger,et al. Metabolomics applied to exhaled breath condensate in childhood asthma. , 2007, American journal of respiratory and critical care medicine.
[14] B. Hammock,et al. Mass spectrometry-based metabolomics. , 2007, Mass spectrometry reviews.
[15] A. Custovic,et al. Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma , 2013, Allergy.
[16] Michael A Kennedy,et al. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis , 2011, Arthritis research & therapy.
[17] O. Fiehn. Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.
[18] F. Reniero,et al. Asthma severity in childhood and metabolomic profiling of breath condensate , 2013, Allergy.
[19] Zhe Chen,et al. (1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis. , 2012, Experimental and therapeutic medicine.
[20] V. Valderrábano,et al. Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy. , 2012, Clinical and experimental rheumatology.
[21] I. Pavord,et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.
[22] B. Canning. Modeling asthma and COPD in animals: a pointless exercise? , 2003, Current opinion in pharmacology.
[23] Frederick Wolfe,et al. Rheumatoid arthritis , 2010, The Lancet.
[24] Hans Bisgaard,et al. Prevalence of asthma‐like symptoms in young children , 2007, Pediatric pulmonology.
[25] E Holmes,et al. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. , 2002, The Analyst.
[26] P. Howarth,et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.
[27] Erik J. Saude,et al. Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. , 2009, American journal of respiratory and critical care medicine.
[28] I. Pavord,et al. Biomarkers Predicting Response to Corticosteroid Therapy in Asthma , 2005, Treatments in respiratory medicine.
[29] M. Fitzpatrick,et al. Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis , 2013, Arthritis and rheumatism.
[30] M. Viant,et al. The Impact of Inflammation on Metabolomic Profiles in Patients With Arthritis , 2013, Arthritis and rheumatism.
[31] L. Hood,et al. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.
[32] L. Yao,et al. Rapid Resolution Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics Approach to Study the Effects of Jieduquyuziyin Prescription on Systemic Lupus Erythematosus , 2014, PloS one.
[33] Thomas Bieber,et al. Atopic dermatitis. , 2008, The New England journal of medicine.
[34] Ara W. Darzi,et al. Metabolic phenotyping in clinical and surgical environments , 2012, Nature.
[35] A. Laptook,et al. Effects of Lactic Acid Infusions and pH on Cerebral Blood Flow and Metabolism , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] Zhe Chen,et al. 1H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis , 2012 .
[37] T. Bieber. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine , 2012, Allergy.
[38] J. Meulman,et al. Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements , 2012, PloS one.
[39] T. Bieber,et al. Atopic dermatitis: a candidate for disease‐modifying strategy , 2012, Allergy.
[40] J. Hanifin. Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. , 2009, The Journal of investigative dermatology.
[41] Lx Wang,et al. 1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus , 2011, Lupus.
[42] K. Takabayashi,et al. Decreased Regional Cerebral Metabolic Rate for Glucose in Systemic Lupus erythematosus Patients with Psychiatric Symptoms , 1999, European Neurology.
[43] C. Guillou,et al. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. , 2012, Biomedical chromatography : BMC.
[44] G. Hwang,et al. Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[45] J. Griffin. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[46] Hongwei Kong,et al. Plasma metabonomics study of rheumatoid arthritis and its Chinese medicine subtypes by using liquid chromatography and gas chromatography coupled with mass spectrometry. , 2012, Molecular bioSystems.
[47] Cheng Xiao,et al. Correlation between cold and hot pattern in traditional Chinese medicine and gene expression profiles in rheumatoid arthritis , 2011, Frontiers of medicine.
[48] R. Bennett,et al. 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. , 2010, Journal of proteome research.
[49] N. Gibbs,et al. Recent advances in urocanic acid photochemistry, photobiology and photoimmunology , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[50] Johan Trygg,et al. Chemometrics in metabonomics. , 2007, Journal of proteome research.
[51] H. Zeidler. The Need to Better Classify and Diagnose Early and Very Early Rheumatoid Arthritis , 2012, The Journal of Rheumatology.
[52] M. Giera,et al. Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. , 2012, Biochimica et biophysica acta.
[53] C. Zwingmann,et al. MRL/lpr mice have alterations in brain metabolism as shown with [1H–13C] NMR spectroscopy , 2005, Neurochemistry International.
[54] J. Schoones,et al. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review , 2013, Annals of the rheumatic diseases.
[55] H. Vogel,et al. An inflammatory arthritis-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy. , 2007, Journal of proteome research.
[56] Erik J. Saude,et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. , 2011, The Journal of allergy and clinical immunology.
[57] Chandra Mohan,et al. Metabolic Disturbances Associated with Systemic Lupus Erythematosus , 2012, PloS one.
[58] J. Kreidberg,et al. Development of the renal glomerulus: good neighbors and good fences , 2008, Development.
[59] A. Fryer,et al. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.
[60] D. Fabian,et al. The global burden of asthma: executive summary of the GINA Dissemination Committee Report , 2004, Allergy.
[61] H. Hagino,et al. Nuclear magnetic resonance studies of synovial fluids from patients with rheumatoid arthritis and osteoarthritis. , 1999, Clinica chimica acta; international journal of clinical chemistry.